{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T17:29:04Z","timestamp":1772213344196,"version":"3.50.1"},"reference-count":128,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jaip.2021.08.002","type":"journal-article","created":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T01:27:51Z","timestamp":1633656471000},"page":"3584-3597","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Evaluation of Adverse Reactions to Vaccines"],"prefix":"10.1016","volume":"9","author":[{"given":"Anne","family":"Des Roches","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Begin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Paradis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Gold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2021.08.002_bib2","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1056\/NEJMp1905099","article-title":"Measles in 2019\u2014going backward","volume":"380","author":"Paules","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.08.002_bib5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev-publhealth-090419-102240","article-title":"Vaccine Hesitancy, acceptance, and anti-vaccination: trends and future prospects for public health","volume":"42","author":"Dube","year":"2021","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.jaip.2021.08.002_bib6","series-title":"Causality assessment of an adverse event following immunization (AEFI)","year":"2019"},{"key":"10.1016\/j.jaip.2021.08.002_bib7","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1586\/14760584.2014.942223","article-title":"Intussusception following rotavirus vaccination: an updated review of the available evidence","volume":"13","author":"Rha","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.jaip.2021.08.002_bib8","doi-asserted-by":"crossref","first-page":"6202","DOI":"10.1016\/j.vaccine.2018.08.008","article-title":"Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines\u2014multi-country assessment","volume":"36","author":"Weibel","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.jaip.2021.08.002_bib9","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.08.002_bib10","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1080\/21645515.2016.1192737","article-title":"Adverse events following HPV immunization in Australia: establishment of a clinical network","volume":"12","author":"Crawford","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jaip.2021.08.002_bib11","doi-asserted-by":"crossref","first-page":"e384","DOI":"10.1097\/INF.0000000000001323","article-title":"Immunizing patients with adverse events after immunization and potential contraindications to immunization: a report from the special immunization clinics network","volume":"35","author":"Top","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaip.2021.08.002_bib12","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1016\/j.vaccine.2011.07.044","article-title":"Overview of the clinical consult case review of adverse events following immunization: Clinical Immunization Safety Assessment (CISA) network 2004-2009","volume":"29","author":"Williams","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jaip.2021.08.002_bib13","doi-asserted-by":"crossref","first-page":"9315","DOI":"10.1021\/acsnano.9b03942","article-title":"Pseudo-anaphylaxis to polyethylene glycol (PEG)-coated liposomes: roles of anti-PEG IgM and complement activation in a porcine model of human infusion reactions","volume":"13","author":"Kozma","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jaip.2021.08.002_bib14","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaci.2020.01.017","article-title":"Anaphylaxis-a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis","volume":"145","author":"Shaker","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.08.002_bib15","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jaci.2017.12.971","article-title":"Vaccine-associated hypersensitivity","volume":"141","author":"McNeil","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.08.002_bib16","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/pai.12762","article-title":"Vaccination and allergy: EAACI position paper, practical aspects","volume":"28","author":"Nilsson","year":"2017","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2021.08.002_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaci.2012.04.003","article-title":"Adverse reactions to vaccines practice parameter 2012 update","volume":"130","author":"Kelso","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.08.002_bib18","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jaci.2011.02.013","article-title":"Single-dose influenza vaccination of patients with egg allergy in a multicenter study","volume":"128","author":"Webb","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.08.002_bib19","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.anai.2011.01.024","article-title":"Safe administration of seasonal influenza vaccine to children with egg allergy of all severities","volume":"106","author":"Howe","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.08.002_bib20","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.anai.2012.09.011","article-title":"Safe administration of the seasonal trivalent influenza vaccine to children with severe egg allergy","volume":"109","author":"Greenhawt","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.08.002_bib21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.anai.2010.08.015","article-title":"The safety of the H1N1 influenza A vaccine in egg allergic individuals","volume":"105","author":"Greenhawt","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.08.002_bib22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jaci.2010.05.037","article-title":"Safe vaccination of patients with egg allergy with an adjuvanted pandemic H1N1 vaccine","volume":"126","author":"Gagnon","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.08.002_bib23","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.jaci.2012.07.046","article-title":"Egg-allergic patients can be safely vaccinated against influenza","volume":"130","author":"Des Roches","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.08.002_bib24","doi-asserted-by":"crossref","first-page":"e1024","DOI":"10.1542\/peds.2009-2512","article-title":"Safety of influenza vaccine administration in egg-allergic patients","volume":"125","author":"Chung","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2021.08.002_bib25","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S1473-3099(19)30355-X","article-title":"Yellow fever vaccine and egg allergy","volume":"19","author":"Cancado","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jaip.2021.08.002_bib26","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.26633\/RPSP.2018.75","article-title":"Yellow fever vaccine and risk of developing serious adverse events: a systematic review","volume":"42","author":"Porudominsky","year":"2018","journal-title":"Rev Panam Salud Publica"},{"key":"10.1016\/j.jaip.2021.08.002_bib27","doi-asserted-by":"crossref","first-page":"6539","DOI":"10.1016\/j.vaccine.2020.08.020","article-title":"Safety of yellow fever vaccine administration in confirmed egg-allergic patients","volume":"38","author":"Gerhardt","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.jaip.2021.08.002_bib28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jaci.2011.04.046","article-title":"Anaphylaxis to diphtheria, tetanus, and pertussis vaccines among children with cow's milk allergy","volume":"128","author":"Kattan","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.08.002_bib29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/cea.12059","article-title":"Hypersensitivity reactions to the Sabin vaccine in children with cow's milk allergy","volume":"43","author":"Parisi","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2021.08.002_bib30","first-page":"128","article-title":"MMR vaccine and neomycin allergy","volume":"147","author":"Kwittken","year":"1993","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.jaip.2021.08.002_bib32","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.vaccine.2004.06.042","article-title":"Vaccination of persons allergic to latex: a review of safety data in the Vaccine Adverse Event Reporting System (VAERS)","volume":"23","author":"Russell","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.jaip.2021.08.002_bib33","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/DER.0b013e31825228cf","article-title":"Hypersensitivity reactions to vaccine constituents: a case series and review of the literature","volume":"23","author":"Leventhal","year":"2012","journal-title":"Dermatitis"},{"key":"10.1016\/j.jaip.2021.08.002_bib34","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jaci.2015.08.001","article-title":"Highly increased levels of IgE antibodies to vaccine components in children with influenza vaccine-associated anaphylaxis","volume":"137","author":"Nagao","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.08.002_bib35","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/pai.12548","article-title":"Anaphylaxis to pneumococcal vaccine; CRM(197): novel cause of vaccine allergy","volume":"27","author":"Arroabarren","year":"2016","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2021.08.002_bib36","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1056\/NEJMra2035343","article-title":"Maintaining safety with SARS-CoV-2 vaccines","volume":"384","author":"Castells","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.08.002_bib37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.15585\/mmwr.mm7004e1","article-title":"Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine\u2014United States, December 21, 2020-January 10, 2021","volume":"70","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaip.2021.08.002_bib38","doi-asserted-by":"crossref","first-page":"46","DOI":"10.15585\/mmwr.mm7002e1","article-title":"Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine\u2014United States, December 14-23, 2020","volume":"70","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaip.2021.08.002_bib39","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/cea.12760","article-title":"Immediate-type hypersensitivity to polyethylene glycols: a review","volume":"46","author":"Wenande","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2021.08.002_bib40","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.jaip.2020.12.047","article-title":"mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: current evidence and suggested approach","volume":"9","author":"Banerji","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.08.002_bib41","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.1016\/j.vaccine.2013.10.033","article-title":"Increased risk of anaphylaxis following administration of 2009 AS03-adjuvanted monovalent pandemic A\/H1N1 (H1N1pdm09) vaccine","volume":"31","author":"Rouleau","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jaip.2021.08.002_bib42","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jaci.2007.04.035","article-title":"Clinical immunization safety assessment network hypersensitivity working G. Irritant skin test reactions to common vaccines","volume":"120","author":"Wood","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.08.002_bib43","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/j.1398-9995.2011.02698.x","article-title":"Spontaneous resolution of diphtheria-tetanus vaccine hypersensitivity in a pediatric population","volume":"66","author":"Begin","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.08.002_bib44","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1586\/14760584.2014.933079","article-title":"Administering influenza vaccine to egg-allergic persons","volume":"13","author":"Kelso","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.jaip.2021.08.002_bib45","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1086\/375820","article-title":"Extensive limb swelling after immunization: reports to the Vaccine Adverse Event Reporting System","volume":"37","author":"Woo","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2021.08.002_bib46","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1542\/peds.105.1.e12","article-title":"Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines","volume":"105","author":"Rennels","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2021.08.002_bib47","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0264-410X(03)00531-0","article-title":"Unexpectedly high incidence of persistent itching nodules and delayed hypersensitivity to aluminium in children after the use of adsorbed vaccines from a single manufacturer","volume":"22","author":"Bergfors","year":"2003","journal-title":"Vaccine"},{"issue":"Suppl 3","key":"10.1016\/j.jaip.2021.08.002_bib48","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S0264-410X(02)00166-4","article-title":"Aluminum salts in vaccines\u2014US perspective","volume":"20","author":"Baylor","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.jaip.2021.08.002_bib49","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s00431-014-2318-2","article-title":"How common are long-lasting, intensely itching vaccination granulomas and contact allergy to aluminium induced by currently used pediatric vaccines? A prospective cohort study","volume":"173","author":"Bergfors","year":"2014","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jaip.2021.08.002_bib50","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00431-012-1841-2","article-title":"Sixty-four children with persistent itching nodules and contact allergy to aluminium after vaccination with aluminium-adsorbed vaccines-prognosis and outcome after booster vaccination","volume":"172","author":"Bergfors","year":"2013","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jaip.2021.08.002_bib52","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/cod.12053","article-title":"Unexpected loss of contact allergy to aluminium induced by vaccine","volume":"68","author":"Gente Lidholm","year":"2013","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2021.08.002_bib53","doi-asserted-by":"crossref","first-page":"240","DOI":"10.5694\/mja11.11484","article-title":"Stevens-Johnson syndrome after varicella vaccination","volume":"196","author":"Christou","year":"2012","journal-title":"Med J Aust"},{"key":"10.1016\/j.jaip.2021.08.002_bib54","article-title":"Vaccine-induced toxic epidermal necrolysis: a case and systematic review","volume":"24","author":"Chahal","year":"2018","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jaip.2021.08.002_bib55","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/bcp.13512","article-title":"First case of Stevens-Johnson syndrome after rabies vaccination","volume":"84","author":"Ma","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaip.2021.08.002_bib56","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/1346-8138.13487","article-title":"Influenza vaccine-induced acute generalized exanthematous pustulosis during pregnancy","volume":"44","author":"Matsuo","year":"2017","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.jaip.2021.08.002_bib57","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41541-018-0059-3","article-title":"Immune system correlates of extensive limb swelling in response to conjugated pneumococcal vaccination","volume":"3","author":"Recher","year":"2018","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.jaip.2021.08.002_bib58","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/ACI.0b013e32833aa54d","article-title":"Patch testing in drug allergy","volume":"10","author":"Friedmann","year":"2010","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.08.002_bib59","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00130832-200108000-00009","article-title":"Recent advances in the diagnosis of drug allergy","volume":"1","author":"Primeau","year":"2001","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"Suppl 2","key":"10.1016\/j.jaip.2021.08.002_bib60","first-page":"S607","article-title":"Serum sickness and hepatitis B vaccine including review of the literature","volume":"85","author":"Arkachaisri","year":"2002","journal-title":"J\u00a0Med Assoc Thai"},{"key":"10.1016\/j.jaip.2021.08.002_bib61","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2015-211917","article-title":"Serum sickness-like reaction after influenza vaccination","volume":"2015","author":"Chiong","year":"2015","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jaip.2021.08.002_bib62","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/MAJ.0b013e318273de7f","article-title":"Severe serum sickness after H1N1 influenza vaccination","volume":"345","author":"Bonds","year":"2013","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jaip.2021.08.002_bib63","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1086\/599615","article-title":"Serum sickness-like reaction associated with inactivated influenza vaccination among Thai health care personnel: risk factors and outcomes","volume":"49","author":"Apisarnthanarak","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2021.08.002_bib64","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1258\/095646206775809123","article-title":"Severe serum sickness following pneumococcal vaccination in an AIDS patient","volume":"17","author":"Hengge","year":"2006","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.jaip.2021.08.002_bib65","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0091-6749(87)80156-2","article-title":"Immunologic studies in subjects with a serum sickness-like illness after immunization with human diploid cell rabies vaccine","volume":"79","author":"Warrington","year":"1987","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.08.002_bib66","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1001\/jama.1972.03200120067033","article-title":"Serum sickness and tetanus immunization","volume":"220","author":"Daschbach","year":"1972","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2021.08.002_bib67","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.jaip.2020.08.047","article-title":"Differentiating between beta-lactam-induced serum sickness-like reactions and viral exanthem in children using a graded oral challenge","volume":"9","author":"Delli Colli","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.08.002_bib68","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barre syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2021.08.002_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6703a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2018-19 influenza season","volume":"67","author":"Grohskopf","year":"2018","journal-title":"MMWR Recomm Rep"},{"issue":"RR-3","key":"10.1016\/j.jaip.2021.08.002_bib70","first-page":"1","article-title":"Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Broder","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jaip.2021.08.002_bib71","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S1521-6616(03)00046-9","article-title":"Influenza vaccination and Guillain Barre syndrome","volume":"107","author":"Geier","year":"2003","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaip.2021.08.002_bib72","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.autrev.2013.10.003","article-title":"The spectrum of post-vaccination inflammatory CNS demyelinating syndromes","volume":"13","author":"Karussis","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaip.2021.08.002_bib73","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1016\/j.vaccine.2007.04.060","article-title":"Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"25","author":"Sejvar","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jaip.2021.08.002_bib74","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0887-8994(92)90036-X","article-title":"Acute disseminated encephalomyelitis after Japanese B encephalitis vaccination","volume":"8","author":"Ohtaki","year":"1992","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jaip.2021.08.002_bib75","series-title":"Adverse effects of vaccines: evidence and causality","year":"2011"},{"key":"10.1016\/j.jaip.2021.08.002_bib76","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1016\/j.vaccine.2016.06.062","article-title":"Safety of DTaP-IPV\/Hib vaccine administered routinely to infants and toddlers","volume":"34","author":"Hansen","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.jaip.2021.08.002_bib77","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/088307389601100218","article-title":"Fatal mumps meningoencephalitis in a child with severe combined immunodeficiency after bone marrow transplantation","volume":"11","author":"Bakshi","year":"1996","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.jaip.2021.08.002_bib78","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00006454-198701000-00015","article-title":"Measles virus in the cerebrospinal fluid in postvaccination immunosuppressive measles encephalopathy","volume":"6","author":"Valmari","year":"1987","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaip.2021.08.002_bib79","first-page":"249","article-title":"Acute necrotizing measles encephalitis in a child with AIDS","volume":"242","author":"Lacroix","year":"1995","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.jaip.2021.08.002_bib80","first-page":"548","article-title":"Acute meningoencephalitis immediately after an influenza vaccination [in French]","volume":"23","author":"Froissart","year":"1978","journal-title":"Lille Med"},{"key":"10.1016\/j.jaip.2021.08.002_bib81","doi-asserted-by":"crossref","first-page":"187","DOI":"10.55782\/ane-2010-1790","article-title":"Does thimerosal or other mercury exposure increase the risk for autism? A review of current literature","volume":"70","author":"Schultz","year":"2010","journal-title":"Acta Neurobiol Exp (Wars)"},{"key":"10.1016\/j.jaip.2021.08.002_bib82","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1542\/peds.2004-0434","article-title":"Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data","volume":"114","author":"Parker","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2021.08.002_bib83","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1016\/j.vaccine.2014.04.085","article-title":"Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies","volume":"32","author":"Taylor","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jaip.2021.08.002_bib84","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/ana.22587","article-title":"Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China","volume":"70","author":"Han","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaip.2021.08.002_bib85","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.smrv.2017.06.006","article-title":"Incidence of narcolepsy after H1N1 influenza and vaccinations: systematic review and meta-analysis","volume":"38","author":"Sarkanen","year":"2018","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.jaip.2021.08.002_bib86","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/0140-6736(92)90571-J","article-title":"DQ (rather than DR) gene marks susceptibility to narcolepsy","volume":"339","author":"Matsuki","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2021.08.002_bib87","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1101\/gr.8.5.427","article-title":"Genetic studies in the sleep disorder narcolepsy","volume":"8","author":"Kadotani","year":"1998","journal-title":"Genome Res"},{"key":"10.1016\/j.jaip.2021.08.002_bib88","doi-asserted-by":"crossref","first-page":"E12323","DOI":"10.1073\/pnas.1818150116","article-title":"Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy","volume":"115","author":"Luo","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaip.2021.08.002_bib89","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2165\/11530350-000000000-00000","article-title":"Association between drug and vaccine use and acute immune thrombocytopenia in childhood: a case-control study in Italy","volume":"33","author":"Bertuola","year":"2010","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaip.2021.08.002_bib90","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.4161\/hv.23601","article-title":"Vaccine administration and the development of immune thrombocytopenic purpura in children","volume":"9","author":"Cecinati","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jaip.2021.08.002_bib91","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1542\/peds.2011-1111","article-title":"The risk of immune thrombocytopenic purpura after vaccination in children and adolescents","volume":"129","author":"O'Leary","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2021.08.002_bib92","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1016\/j.vaccine.2011.06.009","article-title":"A\u00a0collaborative approach to investigating the risk of thrombocytopenic purpura after measles-mumps-rubella vaccination in England and Denmark","volume":"30","author":"Andrews","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jaip.2021.08.002_bib93","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMe2106315","article-title":"SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia","volume":"384","author":"Cines","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.08.002_bib94","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.08.002_bib95","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.08.002_bib96","doi-asserted-by":"crossref","first-page":"329","DOI":"10.15585\/mmwr.mm7009e4","article-title":"The Advisory Committee on Immunization Practices' interim recommendation for use of Janssen COVID-19 vaccine\u2014United States, February 2021","volume":"70","author":"Oliver","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaip.2021.08.002_bib97","doi-asserted-by":"crossref","first-page":"651","DOI":"10.15585\/mmwr.mm7017e4","article-title":"Updated recommendations from the Advisory Committee on Immunization Practices for use of the Janssen (Johnson & Johnson) COVID-19 vaccine after reports of thrombosis with thrombocytopenia syndrome among vaccine recipients\u2014United States, April 2021","volume":"70","author":"MacNeil","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaip.2021.08.002_bib98","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ajem.2021.05.054","article-title":"Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines","volume":"49","author":"Long","year":"2021","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jaip.2021.08.002_bib102","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1086\/378274","article-title":"Randomized, double-blind, placebo-controlled trial to assess the rate of recurrence of oculorespiratory syndrome following influenza vaccination among persons previously affected","volume":"37","author":"Skowronski","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2021.08.002_bib103","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1001\/archinte.164.20.2266","article-title":"Recurrence risk of oculorespiratory syndrome after influenza vaccination: randomized controlled trial of previously affected persons","volume":"164","author":"De Serres","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaip.2021.08.002_bib104","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1086\/368189","article-title":"Ocular and respiratory symptoms attributable to inactivated split influenza vaccine: evidence from a controlled trial involving adults","volume":"36","author":"Scheifele","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2021.08.002_bib105","first-page":"1","article-title":"Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2013-2014","volume":"62","author":"Grohskopf","year":"2014","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jaip.2021.08.002_bib106","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1086\/513807","article-title":"HLA-DR class II associations with rubella vaccine-induced joint manifestations","volume":"177","author":"Mitchell","year":"1998","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jaip.2021.08.002_bib107","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1111\/bcp.14112","article-title":"Immune-mediated adverse reactions to vaccines","volume":"85","author":"Stone","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaip.2021.08.002_bib108","doi-asserted-by":"crossref","first-page":"e646","DOI":"10.1542\/peds.2007-1653","article-title":"Prospective assessment of the effect of needle length and injection site on the risk of local reactions to the fifth diphtheria-tetanus-acellular pertussis vaccination","volume":"121","author":"Jackson","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2021.08.002_bib109","first-page":"CD010720","article-title":"Needle size for vaccination procedures in children and adolescents","volume":"8","author":"Beirne","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2021.08.002_bib110","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1542\/peds.2008-0939","article-title":"Febrile seizures: clinical practice guideline for the long-term management of the child with simple febrile seizures","volume":"121","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2021.08.002_bib111","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.pediatrneurol.2017.08.005","article-title":"Febrile seizure risk after vaccination in children one to five months of age","volume":"76","author":"Duffy","year":"2017","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jaip.2021.08.002_bib112","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.vaccine.2012.01.027","article-title":"Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011","volume":"30","author":"Tse","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jaip.2021.08.002_bib113","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1001\/jama.2012.165","article-title":"Risk of febrile seizures and epilepsy after vaccination with diphtheria, tetanus, acellular pertussis, inactivated poliovirus, and Haemophilus influenzae type B","volume":"307","author":"Sun","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2021.08.002_bib114","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0264-410X(97)00191-6","article-title":"Temporal relationship modeling: DTP or DT immunizations and infantile spasms","volume":"16","author":"Goodman","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.jaip.2021.08.002_bib115","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1303164","article-title":"Intussusception risk after rotavirus vaccination in U.S. infants","volume":"370","author":"Yih","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.08.002_bib116","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1126\/science.287.5452.491","article-title":"Role of the enteric nervous system in the fluid and electrolyte secretion of rotavirus diarrhea","volume":"287","author":"Lundgren","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.jaip.2021.08.002_bib117","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1348-0421.2000.tb02542.x","article-title":"Rotavirus infection and intussusception: a view from retrospect","volume":"44","author":"Nakagomi","year":"2000","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.jaip.2021.08.002_bib118","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jaci.2014.02.028","article-title":"BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies","volume":"133","author":"Marciano","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.08.002_bib119","doi-asserted-by":"crossref","first-page":"7231","DOI":"10.1016\/j.vaccine.2017.11.013","article-title":"Herpes zoster vaccine live: a 10 year review of post-marketing safety experience","volume":"35","author":"Willis","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.jaip.2021.08.002_bib120","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.15585\/mmwr.mm6742a5","article-title":"Update on vaccine-derived polioviruses\u2014worldwide, January 2017-June 2018","volume":"67","author":"Jorba","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaip.2021.08.002_bib121","author":"Canada"},{"key":"10.1016\/j.jaip.2021.08.002_bib122","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1001\/archdermatol.2010.46","article-title":"Adverse events following smallpox vaccination with ACAM2000 in a military population","volume":"146","author":"Beachkofsky","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2021.08.002_bib123","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1086\/520449","article-title":"Measles inclusion-body encephalitis caused by the vaccine strain of measles virus","volume":"29","author":"Bitnun","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2021.08.002_bib124","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4269\/ajtmh.2012.11-0525","article-title":"The safety of yellow fever vaccine 17D or 17DD in children, pregnant women, HIV+ individuals, and older persons: systematic review","volume":"86","author":"Thomas","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jaip.2021.08.002_bib125","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1016\/j.vaccine.2010.07.039","article-title":"Severe combined immunodeficiency (SCID) and rotavirus vaccination: reports to the Vaccine Adverse Events Reporting System (VAERS)","volume":"28","author":"Bakare","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jaip.2021.08.002_bib126","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.anai.2018.11.002","article-title":"The effect of delayed and early diagnosis in siblings, and importance of newborn screening for SCID","volume":"122","author":"Krantz","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.08.002_bib127","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.anai.2017.02.025","article-title":"A\u00a0case of atypical, complete DiGeorge syndrome without 22q11 mutation","volume":"118","author":"Stone","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.08.002_bib128","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4161\/hv.4.1.4747","article-title":"Evidence based route of administration of vaccines","volume":"4","author":"Cook","year":"2008","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.jaip.2021.08.002_bib129","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.vaccine.2005.08.098","article-title":"Definition of needle length required for intramuscular deltoid injection in elderly adults: an ultrasonographic study","volume":"24","author":"Cook","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jaip.2021.08.002_bib130","first-page":"303","article-title":"Don't aim too high: avoiding shoulder injury related to vaccine administration","volume":"45","author":"Cross","year":"2016","journal-title":"Aust Fam Physician"},{"key":"10.1016\/j.jaip.2021.08.002_bib131","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1001\/jama.1997.03540450065037","article-title":"Determination of deltoid fat pad thickness. Implications for needle length in adult immunization","volume":"277","author":"Poland","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2021.08.002_bib132","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.vaccine.2011.10.107","article-title":"Nicolau syndrome may be caused by intravascular vaccine injection","volume":"30","author":"Begin","year":"2012","journal-title":"Vaccine"},{"issue":"Pt 1","key":"10.1016\/j.jaip.2021.08.002_bib133","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1542\/peds.100.3.400","article-title":"Needle length and injection technique for efficient intramuscular vaccine delivery in infants and children evaluated through an ultrasonographic determination of subcutaneous and muscle layer thickness","volume":"100","author":"Groswasser","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2021.08.002_bib134","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1016\/j.vaccine.2020.02.046","article-title":"Immunization stress-related response\u2014redefining immunization anxiety-related reaction as an adverse event following immunization","volume":"38","author":"Gold","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.jaip.2021.08.002_bib136","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1080\/21645515.2019.1577676","article-title":"Mass psychogenic illness following HPV immunization in Carmen de Bolivar, Colombia (2014): more uncertainty is required","volume":"15","author":"Idrovo","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jaip.2021.08.002_bib137","doi-asserted-by":"crossref","first-page":"19575","DOI":"10.2807\/ese.15.21.19575-en","article-title":"Mass psychogenic illness in nationwide in-school vaccination for pandemic influenza A(H1N1) 2009, Taiwan, November 2009-January 2010","volume":"15","author":"Huang","year":"2010","journal-title":"Euro Surveill"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219821009004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219821009004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:29:05Z","timestamp":1761974945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219821009004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":128,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S2213219821009004"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2021.08.002","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Adverse Reactions to Vaccines","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2021.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}